BJH - volume 15, issue 3, may 2024
C. Maquet MD, B. De Prijck MD, A. Jaspers MD, PhD, F. Tassin MD, PhD, A. Keutgens MD, PhD, Y. Beguin MD, PhD, A. De Voeght MD
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare aggressive haematological disease with a grim prognosis. The majority of patients at diagnosis are elderly (typical age range: 60 to 70 years) and seldom fit enough to receive intensive induction therapy. We report here the case of a 76-year-old patient with significant cardiac comorbidity at the time of the diagnosis of BPDCN with bone marrow involvement. He achieved haematologic complete remission with venetoclax as first-line therapy with preservation of a good quality of life, an almost exclusively outpatient care and transfusion independency. The only adverse event was a grade 4 neutropenia without any infectious complication.
(BELG J HEMATOL 2024;15(3):125–9)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
A. Ladang , M. Simul , J. Somja MD, PhD, J. Foguenne , A. Gothot MD, PhD, A. Keutgens MD, PhD, F. Tassin MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
C. Gosset , J. Foguenne , M. Simul , A. Keutgens MD, PhD, F. Tassin MD, PhD, A. Gothot MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
J. Foguenne , M. Simul , R. Keutgens , F. Tassin MD, PhD, C. Bonnet MD, Y. Beguin MD, PhD, M. Jamar MD, PhD, F. Lambert MD, A. Gothot MD, PhD
BJH - 2013, issue BHS Abstractbook, january 2013
K. Hafraoui , J. Caers MD, PhD, F. Tassin MD, PhD, Y. Beguin MD, PhD
Top
